IL22 and COVID-19: Mechanically, IL-22 has been reported to be robustly expressed by SARS-CoV-2-specific CD4+ T cells, and IL-22 is closely related to tissue repair, especially in lung epithelial cells, suggesting that SARS-CoV-2 CD4+ T cell response may play an active role in lung tissue repair during COVID-19.